Interactive Stock Charts provided by WD SOFTWARE
 
 
 

Fund Name: iShares Nasdaq Biotechnology Index Fund

Ticker: IBB

Listed On: U.S. AMEX exchange, Fund Manager: iShares

Issuer: iShares Nasdaq Biotechnology Index Fund

Open: empty, Prev Close: 80.33

Prev Volume: 390170

Yesterday's Range: empty, 52 Week Range: 100.4 - 80.33


Cusip: 464287556

Marginable: --

Option Tradable: --

Short Selling: --

Derivatives: --

Inception share price: $99.66

Inception date: February 05, 2001


Shortcuts: Dividends, Holdings, Monthly Data, Semi Annual Data, Expenses

The iShares Nasdaq Biotechnology Index Fund seeks to provide investment results generally equivalent to companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.


 
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
 
 

Manager Name: Diane Hsiung

ManagerFromTo
Diane Hsiung

Dividends:

Payable DateEx DateDistribution AmountLong GainShort Gain
Jun 30, 2008Jun 24, 20080.176600
Jul 06, 2007Jun 29, 20070.088500

Holdings:

DateHoldingDollar Value% of Total Portfolio
Mar 31, 2009AMGEN INC$147,566,000.0011.47
Mar 31, 2009MYRIAD GENETICS INC$36,824,000.002.86
Mar 31, 2009ILLUMINA INC$37,576,000.002.92
Mar 31, 2009VERTEX PHARMACEUTICALS INC$40,651,000.003.16
Mar 31, 2009GENZYME CORP$51,607,000.004.01
Mar 31, 2009BIOGEN IDEC INC$55,085,000.004.28
Mar 31, 2009CELGENE CORP$81,643,000.006.35
Mar 31, 2009TEVA PHARMACEUTICAL-SP ADR$99,846,000.007.76
Mar 31, 2009GILEAD SCIENCES INC$134,136,000.0010.43
Mar 31, 2009ALEXION PHARMACEUTICALS INC$29,478,000.002.29
 
 

Semi annual Data:

Total net assets:$1,754,913,000
Semi annual fund data date:September 30, 2008
Total common assets:$1,754,913,000
Shares outstanding:21,650,000
Total preferred share assets:--
Leveraged:--
Rolling 3 avg rate:--
Share price:--

Monthly Data:

Fund Data Date:March 31, 2009
Net Value/Share:$66.32
Share Price:--
Premium Discount:0.05%
Distribution / Share:$0.1766
Current Distribution Rate:0.27%
Average Daily Volume:1,230,400

Expenses:

Expense Ratios:--
Expenses management fees:0.48%
Other Expenses:0.00%
Total Expenses:0.48%
 

External links:

 
Statistics
 
7days 3mth 6mth YTD SinceInception
1.7% 16.89% 26.19% 13.06% -20.5%
 
RSS NEWS
  • 19 May 2012, 7:06 am
  • 17 May 2012, 11:58 am
  • 17 May 2012, 11:43 am
  • [at Investopedia] - Biotech ETFs are hitting all-time highs and XBI looks like the best of the group. Because the ETF is already up 25% in 2012 and trading at an all-time high, Id wait for a normal pullback to buy into the ...
  • 16 May 2012, 11:30 am
  • [ETF Trends] - Strong prospects for new drug approvals, a favorable M&A environment, and a positive fundamental outlook have the biotechnology industry looking healthy, according to S&P Capital IQ. Investors who want ...
  • 16 May 2012, 10:37 am
  • [at Forbes] - Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology Index Fund (IBB - News) where we have detected an approximate $182.5 million dollar inflow -- that's a 9.9% increase week over week in outstanding units (from 14,600,000 [...]
  • 14 May 2012, 9:20 am
  • [ETF Trends] - One sector that has held up very well amid weakness in the overall market is biotech. In fact, ETFs tracking the biotech stocks remain near all-time highs on successful drug trial tests and some investors ...
  • 14 May 2012, 6:02 am
  • [GlobeNewswire] - NEW YORK -- The NASDAQ OMX Group, Inc. announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index(R) , which will become effective prior to market open on Monday, May 21, ...
  • 10 May 2012, 11:27 am
  • 8 May 2012, 10:17 am
  • [at Forbes] - Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology Index Fund (IBB - News) where we have detected an approximate $62.2 million dollar outflow -- that's a 3.3% decrease week over week (from 15,100,000 to 14,600,000). Click here [...]
  • 7 May 2012, 5:03 pm
  • [at Investor's Business Daily] - Vertex Drug Study Results Boosts Biotech ETFs
  • 30 April 2012, 9:58 am
  • [at Forbes] - Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology Index Fund (IBB - News) where we have detected an approximate $37.8 million dollar outflow -- that's a 1.9% decrease week over week (from 15,400,000 to 15,100,000). Click here [...]
  • 26 April 2012, 2:22 pm
  • 25 April 2012, 8:59 am
  • [at Seeking Alpha] - Biotech ETFs In Focus: XBI Vs. IBB
  • 20 April 2012, 2:09 pm
  • [ETF Trends] - Coming off the hopeful drug trial tests and lucrative takeover bids, the biotech sector and related exchange traded funds that follow the industry surged this week. However, some biotechnology ETFs are ...
  • 20 April 2012, 10:13 am
  • [at Forbes] - Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology Index Fund (NASD: IBB - News) where we have detected an approximate $30.2 million dollar inflow -- that's a 1.7% increase week over week in outstanding units (from 15,150,000 [...]
  • 19 April 2012, 9:55 am
  • [ETF Trends] - Biotech ETFs were the strongest market sector by far in early trading Thursday as portfolio holdings Human Genome Sciences (NasdaqGS: HGSI - News) and Gilead Sciences (NasdaqGS: GILD - News) soared on a takeover bid ...
  • 10 April 2012, 10:45 am
  • [at Forbes] - Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Nasdaq Biotechnology Index Fund (NASD: IBB - News) where we have detected an approximate $30.4 million dollar inflow -- that's a 1.7% increase week over week in outstanding units (from 14,900,000 [...]
  • 5 April 2012, 9:10 am
  • 5 April 2012, 2:19 am
  • 30 March 2012, 4:00 am
 

Latest Tweets on $IBB
  • 28 December 2010, 9:35 am
  • 22 December 2010, 10:07 am
  • 22 December 2010, 8:45 am
 

Recent forum topics

 
Get Summary For Symbol

Last Updated on: 2010-01-14 02:03:40

 
 
Quotes are updated automatically. Quotes are delayed. Etftips.com has not reviewed, and in no way endorses the validity the data. Etftips.com shall not be liable for any actions taken in thereon. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Etftips.com nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any action taken in reliance on information contained herein. By accessing the Etftips.com site, you agree not to redistribute the information found herein. ETF Values can go up as well as down.
 
Copyright EtfTips.com ©2009